Follow NNIT

Your Licence to Sell is at Stake

News   •   Aug 06, 2014 11:10 CEST

With an approaching serialisation deadline, following the introduction of new legislation in the pharmaceuticals market to deal with the threat of counterfeit drugs, Clinical Trials Insight talks to Lars Højberg, life sciences expert at NNIT, about the best strategy for complying with serialisation.

Read the article here

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.